Cite
HARVARD Citation
Yan, L. et al. (2021). Sequential CD19 and BCMA‐specific CAR T‐cell treatment elicits sustained remission of relapsed and/or refractory myeloma. Cancer medicine. pp. 563-574. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yan, L. et al. (2021). Sequential CD19 and BCMA‐specific CAR T‐cell treatment elicits sustained remission of relapsed and/or refractory myeloma. Cancer medicine. pp. 563-574. [Online].